Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2007
06/27/2007CN1986798A Japahese blood fluke epidermal antigen gene and its coded protein and application
06/27/2007CN1986797A Japanese blood fluke epidermal antigen gene and its coded protein and application
06/27/2007CN1986794A Light and heavy chain variable region gene of monoclonal antibody for resisting protective anthrax bacillus antigen and its application
06/27/2007CN1986569A Humanized respiratory syncytial virus-resisting neutralizing gentically engineered Fab antibody
06/27/2007CN1323167C Muteins of placental growth factor type 1, preparing method and application thereof
06/27/2007CN1323162C Paramycobacterial diagnostics and vaccines
06/27/2007CN1323088C Method for producing tetanic immunoglobulin
06/27/2007CN1322897C Use of IL-18 inhibitors
06/26/2007US7235644 Vaccine against Gram-negative bacterial infections
06/26/2007US7235643 Substituting an amino acid within the variable domain of the heavy or light chain of the monoclonal antibody wherein above amino acid containing a nonpolar side chain, with a proline
06/26/2007US7235642 Anti-PRO 1313 antibodies
06/26/2007US7235641 Bispecific antibodies
06/26/2007US7235640 Isolated antibodies to a secretory membrane protein
06/26/2007US7235637 IL-1 eta DNA and polypeptides
06/26/2007US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
06/26/2007US7235633 Cytokine receptors and nucleic acids encoding the same
06/26/2007US7235632 for diagnosing malignant and benign hemopathies; isolated human cell surface protein wherein said protein; expressed at the surface of human lymphoid progenitor cells and mature NK cells
06/26/2007US7235631 For altering T cell-mediated immune responses
06/26/2007US7235630 PRO994 polypeptides
06/26/2007US7235395 Lactic acid bacteria as agents for treating and preventing allergy
06/26/2007US7235381 Expressed sequence tags and encoded human proteins
06/26/2007US7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof
06/26/2007US7235376 Gastrin hormone immunoassays
06/26/2007US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample
06/26/2007US7235371 Human osteoclast derived cathepsin
06/26/2007US7235369 Such as horseradish peroxidase conjugated to polylysine carrier and antibody; for use in bioassay/immunoassay
06/26/2007US7235365 Specific binding agents for KSHV vIL-6 that neutralize a biological activity
06/26/2007US7235360 Generating transgenic eukaryotic cells which secrete immunoglobulins using vector transformation and site specific recombination; bioreactors and heterologous gene expression
06/26/2007US7235240 A mutein of IL-15 at least one deletion or substitution in two positions of the amino acid sequence; transplant rejection, autoimmune diseases, inflammatory bowel disease, skin disorders, gatrointestinal disorders, vision defects; antiarthritic, anticarcinogenic, and antidiabetic agents
06/26/2007US7235239 Antibodies to a chemokine expressed in inflamed adenoid
06/26/2007US7235238 Antibodies that bind receptor protein designated 2F1
06/26/2007CA2216827C Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
06/26/2007CA2157118C Isolation of components of interest from milk
06/26/2007CA2065797C Monoclonal antibody, polypeptide and production thereof
06/21/2007WO2007070750A1 Anti-il-17 antibodies
06/21/2007WO2007070708A2 Immunodeficiency viruses
06/21/2007WO2007070538A2 Anti-mn antibodies and methods of using same
06/21/2007WO2007069709A1 Detecting agent and therapeutic agent for highly malignant breast cancer
06/21/2007WO2007069423A1 Diagnostic marker for allergy
06/21/2007WO2007068803A1 Novel neurotrophic factor protein and uses thereof
06/21/2007WO2007068784A1 Novel neurotrophic factor protein and uses thereof
06/21/2007WO2007068758A1 Methods for obtaining immortalized antibody secreting cells
06/21/2007WO2007068750A2 Immunoglobulins directed against nogo
06/21/2007WO2007068488A1 Domain-grafted antibodies
06/21/2007WO2007068485A2 Biological materials and uses thereof
06/21/2007WO2007068429A1 Antibodies against amyloid beta 4 with glycosylated in the variable region
06/21/2007WO2007068412A2 A beta 1-42 specific monoclonal antibodies with therapeutic properties
06/21/2007WO2007068411A2 Therapeutic vaccine
06/21/2007WO2007068354A1 Means and methods for the treatment of tumorous diseases
06/21/2007WO2007068313A2 Targeting and tracing of antigens in living cells
06/21/2007WO2007068255A1 Use of effector-function-deficient antibodies for treatment of auto-immune diseases
06/21/2007WO2007068154A1 A method for preparing specific igy against mutant avian influenza virus and the preparation tηereof
06/21/2007WO2007068105A1 Method of diagnosing amyotrophic lateral sclerosis
06/21/2007WO2007068053A1 Recombinant protein production
06/21/2007WO2007051112A3 Serum prolactin binding protein in epithelial carcinoma
06/21/2007WO2007047291A3 Anti-glypican-3 antibody
06/21/2007WO2007045477A3 Human antibodies against il-13 and therapeutic uses
06/21/2007WO2007035857A3 Treatment of b cell diseases using anti-germline antibody binding agents
06/21/2007WO2007031277A3 Means and methods for diagnosing endometriosis
06/21/2007WO2007027714A3 Engineered anti-il-23 antibodies
06/21/2007WO2007020520A3 Antigenic peptides and their use
06/21/2007WO2007011639A3 Catalytic immunoglobulins
06/21/2007WO2006138429A3 Antibodies against hmgb1 and fragments thereof
06/21/2007WO2006125599A3 Method for the purification of antibodies
06/21/2007WO2006120230A3 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
06/21/2007WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins
06/21/2007WO2006081350A8 Methods and compositions for the diagnosis and treatment of schizophrenia
06/21/2007WO2006063168A3 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases
06/21/2007WO2006020263A3 Cytoxan antibodies and immunoassay
06/21/2007WO2006003388A8 Compositions and methods for treating inflammatory disorders
06/21/2007WO2005005615A3 Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer
06/21/2007WO2004078135A3 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF
06/21/2007WO2003089616A3 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
06/21/2007WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
06/21/2007US20070143878 Nucleotide sequences coding 4-hydroxyphenylpyruvate dioxygenase for use as tool in enhancing quinone concentration in soybean and maize
06/21/2007US20070143871 Non-human transgenic animal models for hepatocellular carcinoma
06/21/2007US20070142641 Atazanavir conjugates and antibodies useful in immunoassay
06/21/2007US20070142627 Sugar-chain-altered anti-hm1.24 antibody
06/21/2007US20070142312 Antigen delivery system
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070141677 Genetic immunization with cationic lipids
06/21/2007US20070141671 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals
06/21/2007US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2)
06/21/2007US20070141644 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders
06/21/2007US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay
06/21/2007US20070141634 Assay
06/21/2007US20070141633 Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein
06/21/2007US20070141600 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
06/21/2007US20070141590 Modulators of tissue regeneration
06/21/2007US20070141579 MUM-1 protein expressed by multiple myeloma-related gene
06/21/2007US20070141566 Methods and materials relating to novel polypeptides and polynucleotides
06/21/2007US20070141088 Glucan-based vaccines
06/21/2007US20070141087 Compounds and methods for diagnosis of tuberculosis
06/21/2007US20070141085 Recombinant protective protein from Streptococcus pneumoniae
06/21/2007US20070141079 Antibody production in farm animals
06/21/2007US20070141075 Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays
06/21/2007US20070141072 Use of multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
06/21/2007US20070141070 Methods and compositions for needleless delivery of antibodies
06/21/2007US20070141068 Methods for the treatment of carcinoma
06/21/2007US20070141065 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation